Dr Eli A Ramirez, MD in Guaynabo, PR - Internal Medicine

Dr Eli A Ramirez, MD is a Internal Medicine - Cardiovascular Disease physician based in Guaynabo, Puerto Rico. Dr Eli A Ramirez is licensed to practice in Puerto Rico (license number 0956) and his current practice location is I7 Calle Ebano, Condo Madreselva Apt 803, Guaynabo, Puerto Rico. He can be reached at his office (for appointments etc.) via phone at (787) 782-3145.

NPI number for Dr Eli A Ramirez is 1518905744 and his current mailing address is I7 Calle Ebano, Condo Madreselva Apt 803, Guaynabo, Puerto Rico. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1518905744.

Contact Information

	Dr Eli A Ramirez, MD
	I7 Calle Ebano, Condo Madreselva Apt 803, Guaynabo, PR 00968-3100
	(787) 782-3145
	Not Available

Physician's Profile

Full Name	Dr Eli A Ramirez
Gender	Male
Speciality	Internal Medicine - Cardiovascular Disease
Location	I7 Calle Ebano, Guaynabo, Puerto Rico
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1518905744
Provider Enumeration Date: 06/02/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Dr Eli A Ramirez such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1518905744	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RC0000X	Internal Medicine - Cardiovascular Disease	0956 (Puerto Rico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Eli A Ramirez is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Eli A Ramirez, MD I7 Calle Ebano, Condo Madreselva Apt 803, Guaynabo, PR 00968-3100 Ph: (787) 782-3145	Dr Eli A Ramirez, MD I7 Calle Ebano, Condo Madreselva Apt 803, Guaynabo, PR 00968-3100 Ph: (787) 782-3145

News Archive

Conformetrix's NMR-based technology to be applied across AstraZeneca's pre-clinical therapeutic pipeline

Conformetrix Ltd, a leader in optimising drug discovery and design, and AstraZeneca announced today that they have signed a research collaboration agreement under which Conformetrix's proprietary NMR-based technology will be applied across AstraZeneca's pre-clinical therapeutic pipeline to enhance lead discovery and hit identification.

Myrexis presents data on MPC-9528 cancer metabolism inhibitor at EORTC/NCI/AACR Symposium

Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today presented two posters at the 22nd European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and American Association for Cancer Research (AACR) Symposium on "Molecular Targets and Cancer Therapeutics," in Berlin, Germany.

Recent objections would eliminate use of routine breast cancer screening mammograms: Authors

The firestorm that followed the November 2009 release of guidelines that would have reduced use of screening mammograms in women aged 40 to 49 highlights challenges for implementing the findings of comparative effectiveness research, according to a new analysis. Meeting such challenges - which may become more common due to increased funding for CER - requires better communication to the public and stakeholders about evidence and its connection to health care quality and efficiency.

Direct-acting antivirals for HCV-related hepatocellular carcinoma reduces the risk of tumor progression

In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), a disease with a high recurrence rate, researchers at the Osaka City University Graduate School of Medicine reported that after receiving cancer treatment, the oral administration of direct-acting antivirals (DAA) reduces the risk of tumor progression following recurrence of the liver disease.

FDA recommends dabigatran etexilate to prevent stroke in AF patients

The U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee today voted 9 to 0 in favour of recommending dabigatran etexilate for stroke prevention in patients with atrial fibrillation (AF).

Internal Medicine Doctors in Guaynabo, PR

Elba Rosa Martin Reyes, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Ave San Patricio # 101, Maramar Plaza Suite 1240, Guaynabo, PR 00968 Phone: 787-508-5445
Elias Bou Prieto, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 59 Ave Esmeralda, Urb. Munoz Rivera, Guaynabo, PR 00969 Phone: 787-720-3234 Fax: 787-272-9729
Dr. Magda Ivette Rodriguez-colon, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 37 Calle Jaime Rodriguez, Urb. Santa Paula, Guaynabo, PR 00969 Phone: 787-790-4339
Dr. Luis F Rodriguez-ospina, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 42 Calle Carazo, Clinica Cardiovascular De Guaynabo, Guaynabo, PR 00969 Phone: 787-720-6376
Dr. Daisy Baez-franceschi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 101 Ave San Patricio, Suite 1010, Guaynabo, PR 00968 Phone: 787-331-0607 Fax: 787-200-2518
Edgardo Jose Adorno-fontanez, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Cond Vista De Los Frailes 150 Carr 873, Apto 54, Guaynabo, PR 00969 Phone: 787-642-6456
Dr. Ricardo Alicea-guevara, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: Guaynabo Medical Mall, Suite 106, 140 Av. Las Cumbres, Guaynabo, PR 00969 Phone: 787-710-2532

Dr Eli A Ramirez, MD - Internal Medicine in Guaynabo, PR